NIH Asks Permission to Keep Tracking Its Free Helpers
Published Date: 12/18/2025
Notice
Summary
The NIH is asking for a 30-day public comment on their request to keep collecting info from special volunteers and guest researchers. This affects people who work or volunteer in NIH research programs and won’t cost anyone extra money. They want to make sure their forms stay approved and easy to use, so the research keeps running smoothly.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
NIH keeps forms for volunteers/researchers
NIH is asking OMB to extend three forms (NIH Form 590, NIH Form 590-1, and NIH Form 590-2; OMB control number 0925-0177, current expiration March 31, 2026) and requests approval for 3 years. People who work or volunteer in NIH intramural research will still need to complete these forms; NIH estimates a total annual burden of 652 hours (2,300 Special Volunteer/Guest Researcher Assignment responses at 6 minutes each, 2,100 Special Volunteer Agreement responses at 5 minutes each, and 200 Guest Researcher Agreement responses at 5 minutes each). There are no monetary costs to respondents other than their time.
Extra 30‑day public comment window
NIH opened an additional 30-day public comment period on this information collection; comments are best assured of full effect if received within 30 days of the December 18, 2025 publication. The earlier 60-day notice (published September 25, 2025) received no public comments, and this notice gives the public another chance to comment.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2025-23249 — Questions and Answers Regarding Mandatory Cosmetics Recalls: Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help cosmetic companies understand how mandatory recalls work and what to expect if their products need to be pulled from shelves. This guide answers common questions about the recall process, making it easier for businesses to stay safe and compliant. Companies should send their feedback by February 17, 2026, so the FDA can finalize the rules—keeping everyone on track and avoiding costly surprises.
Next: 2025-23252 — Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Devices; Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just released updated rules on how real-world data can help approve medical devices faster and smarter. This affects medical device makers and FDA staff by giving clearer, better ways to use everyday health info for decisions. The new guidance starts December 18, 2025, aiming to speed up approvals without extra costs.